Century Therapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
IPSC Nasdaq 2836 www.centurytx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Century Therapeutics, Inc.

Century Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates - Aug 12th, 2026 6:00 am
Century Therapeutics (IPSC) to Present CNTY-813 Data at Scientific Congresses - Jul 14th, 2026 4:33 am
Century Therapeutics Selected for Oral Presentations of CNTY-813 Preclinical Data at EASD 2026 and Breakthrough T1D® Clinical & Research Congress 2026 - Jul 9th, 2026 6:00 am
Cutaneous Lupus Erythematosus Market to Expand at a CAGR of 8% During the Forecast Period (2026–2036) Amid Emerging Therapies and Increasing Healthcare Investments | DelveInsight - Jun 22nd, 2026 11:00 am
Here's Why We're Watching Century Therapeutics' (NASDAQ:IPSC) Cash Burn Situation - Jun 13th, 2026 7:38 am
Century Therapeutics (IPSC) Reports Positive Preclinical Results For Diabetes Cell Therapy CNTY-813 - Jun 10th, 2026 12:22 pm
New CNTY-813 Preclinical Data Demonstrate Durable Glucose Control, Immune Evasion Under Alloimmune Pressure, and Scalable Manufacturing at ADA 2026 - Jun 8th, 2026 2:05 pm
Corbus Pharmaceuticals Appoints Pharma Industry Veteran Brent Pfeiffenberger to Board of Directors - May 14th, 2026 6:00 am
Century Therapeutics Reports First Quarter Financial Results and Business Updates - May 13th, 2026 6:00 am
H.C. Wainwright Remains Bullish on Century Therapeutics (IPSC) - May 1st, 2026 2:18 am
Century Therapeutics Selected for Oral Presentation of CNTY‑813 Preclinical Data at the American Diabetes Association 86th Scientific Sessions - Apr 30th, 2026 2:05 pm
Century Therapeutics Reports Full Year 2025 Financial Results and Business Updates - Mar 12th, 2026 6:00 am
Century Therapeutics to Participate in Upcoming Investor Conferences in March - Feb 25th, 2026 6:00 am
Piper Sandler Highlights Century Therapeutics (IPSC) Cash Runway Through 2029, Upcoming IND Submission - Jan 30th, 2026 12:58 pm
Century Therapeutics (IPSC) Upgraded to Strong Buy: Here's What You Should Know - Jan 22nd, 2026 10:00 am
Promising Penny Stocks To Watch In January 2026 - Jan 16th, 2026 5:05 am
Century Therapeutics Secures Oversubscribed $135 Million Private Placement Financing to Support Lead Program, CNTY-813, a Potentially Curative Therapy for Type 1 Diabetes - Jan 8th, 2026 6:00 am
FDA Grants Breakthrough Therapy Designation to ALKS' Narcolepsy Drug - Jan 7th, 2026 9:45 am
Fast-paced Momentum Stock Century Therapeutics (IPSC) Is Still Trading at a Bargain - Jan 7th, 2026 6:55 am
3 Promising Penny Stocks With Market Caps Over $30M - Dec 18th, 2025 11:05 am